Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07228637 · ClinicalTrials.gov registry record · NA
Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer
A NA study of Testicular Cancer, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT07228637: Active NA study of Testicular Cancer, sponsored by Indiana University.
NCT07228637 is a NA study of Testicular Cancer that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 70 participants, below the 89-participant average among 11 other Testicular Cancer trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07228637, a NA study of Testicular Cancer, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial tests the impact of an Acceptance and Commitment Therapy (ACT)-based coaching program delivered via videoconferencing on fear of cancer recurrence (primary outcome), anxiety, other symptoms, health-related quality of life, and coping (secondary outcomes) in survivors of testicular cancer. ACT includes experiential training in present moment awareness (e.g., mindfulness meditation, performing activities with greater awareness), coping adaptively with difficult internal experiences (e.g., thoughts, feelings, body sensation), identifying personally meaningful values, and pursuing activities consistent with these values. Testicular cancer survivors (N=70) will be randomly assigned in equal numbers to either an ACT-based coaching program or an education/support coaching program, both delivered via videoconferencing. Survivors in both conditions will participate in six weekly 90-minute online group sessions. Outcomes will be assessed at baseline, 2 weeks post-intervention, and 3 months post-intervention. The investigators hypothesize that ACT will lead to improved primary and secondary outcomes as compared to education/support. Study findings will inform a large-scale trial of intervention efficacy.
Primary Outcome
This 7-item measure includes 6 items assessing feelings associated with cancer recurrence and cognitive and behavioral responses to fear of cancer recurrence on 5-point scales (1=not at all to 5=all the time). Question 7 is a single item assessing the extent to which fear of cancer recurrence intrudes on thoughts and activities on a 0-10 scale (0=not at all to 10=a great deal). The 7 items are summed with higher total scores indicating greater fear of cancer recurrence. The total score range is
Conditions Studied
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy (ACT) Coaching
- BEHAVIORAL Education and Support Coaching
Study Locations (1)
Indiana
- Indiana University - Indianapolis - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-08-18 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What the registry record for NCT07228637 still lists
NCT07228637 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 89-participant average among 11 other Testicular Cancer trials with a reported enrollment target (21% lower).
The record links to 1 condition, with Testicular Cancer appearing as the primary indexed condition, and to 2 interventions - of which Acceptance and Commitment Therapy (ACT) Coaching is the first listed.
NCT07228637 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07228637 about?
NCT07228637 is a clinical study titled "Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer". This trial tests the impact of an Acceptance and Commitment Therapy (ACT)-based coaching program delivered via videoconferencing on fear of cancer recurrence (primary outcome), anxiety, other symptoms, health-related quality of life, and coping (secondary outcomes) in survivors of testicular cancer....
What is the current status of trial NCT07228637?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-08-18. Estimated completion is 2026-07-01.
What conditions does trial NCT07228637 study?
This clinical trial studies the following conditions: Testicular Cancer.
What interventions are being tested in trial NCT07228637?
The interventions under investigation include: Acceptance and Commitment Therapy (ACT) Coaching (BEHAVIORAL), Education and Support Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT07228637?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07228637 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Testicular Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07228637's enrollment target sits among peer trials
70 6th of 11 higher than 6 of 11 other Testicular Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Testicular Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
RECRUITING · NA
-
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
RECRUITING · NA
-
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
RECRUITING · NA
-
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
RECRUITING · NA
-
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RECRUITING · Phase 1
-
Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI